Modifying and validating the social responsiveness scale edition 2 for use with deaf children and young people.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 02 06 2020
accepted: 16 11 2020
entrez: 7 12 2020
pubmed: 8 12 2020
medline: 21 1 2021
Statut: epublish

Résumé

A Delphi consensus methodology was used to adapt a screening tool, the Social Responsiveness Scale- 2 (SRS-2), for use with deaf children including those whose preferred communication method is sign language. Using this approach; 27 international experts (The Delphi International Expert Panel), on the topic of autism spectrum disorder (ASD) in deaf people, contributed to the review of item content. A criterion for agreement was set at 80% of experts on each item (with 75% acceptable in the final fourth round). The agreed modifications are discussed. The modified SRS-2 research adaptation for deaf people (referred to here as the "SRS-2 Deaf adaptation") was then translated into British Sign Language using a robust translation methodology and validated in England in a sample of 198 deaf children, 76 with Autism Spectrum Disorders (ASD) and 122 without ASD. The SRS-2 Deaf adaptation was compared blind to a NICE (National Institute for Health and Care Excellence) guideline standard clinical assessment. The area under the Receiver Operating (ROC) curve was 0.811 (95% CI: 0.753, 0.869), with an optimal cut-off value of 73, which gave a sensitivity of 82% and a specificity of 67%. The Cronbach Alpha coefficient was 0.968 suggesting high internal consistency. The Intraclass Correlation Coefficient was 0.897, supporting test-retest reliability. This performance is equivalent to similar instruments used for screening ASD in the hearing population.

Identifiants

pubmed: 33284813
doi: 10.1371/journal.pone.0243162
pii: PONE-D-20-16637
pmc: PMC7721463
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0243162

Subventions

Organisme : Medical Research Council
ID : MR/K015435/1
Pays : United Kingdom

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Autism Dev Disord. 2012 Oct;42(10):2027-37
pubmed: 22290585
Autism. 2003 Sep;7(3):245-53
pubmed: 14516058
J Am Acad Child Adolesc Psychiatry. 2007 Oct;46(10):1324-1332
pubmed: 17885574
J Clin Nurs. 1998 Sep;7(5):451-9
pubmed: 9855997
Cult Med Psychiatry. 2017 Sep;41(3):431-452
pubmed: 28243949
J Autism Dev Disord. 2000 Jun;30(3):205-23
pubmed: 11055457
J Chiropr Med. 2016 Jun;15(2):155-63
pubmed: 27330520
Semin Speech Lang. 2014 Nov;35(4):241-59
pubmed: 25321849
Res Dev Disabil. 2012 May-Jun;33(3):944-50
pubmed: 22277583
BMJ. 2013 Jun 06;346:f3591
pubmed: 23744600
J Deaf Stud Deaf Educ. 2019 Jul 1;24(3):280-288
pubmed: 30839059
Pediatrics. 2005 Dec;116(6):1480-6
pubmed: 16322174
Child Dev. 2007 Mar-Apr;78(2):376-96
pubmed: 17381779
Br J Audiol. 1997 Dec;31(6):409-46
pubmed: 9478287
J Autism Dev Disord. 1994 Oct;24(5):659-85
pubmed: 7814313
Nurse Educ Today. 2001 Jul;21(5):398-408
pubmed: 11403587
Otol Neurotol. 2017 Dec;38(10):1456-1462
pubmed: 28953604
Clin Chem. 2015 Dec;61(12):1446-52
pubmed: 26510957
Child Adolesc Ment Health. 2013 Feb;18(1):52-63
pubmed: 23539140
J Autism Dev Disord. 2003 Aug;33(4):427-33
pubmed: 12959421
J Autism Dev Disord. 2015 Jul;45(7):2128-45
pubmed: 25643865
Respir Med. 2008 Aug;102(8):1089-92
pubmed: 18573646
J Adv Nurs. 1994 Jun;19(6):1221-5
pubmed: 7930104
J Nurs Manag. 1999 Sep;7(5):281-8
pubmed: 10786547
J Deaf Stud Deaf Educ. 2014 Jul;19(3):285-302
pubmed: 24222193
J Autism Dev Disord. 2016 Jun;46(6):1974-1984
pubmed: 27032954
J Child Psychol Psychiatry. 1997 Oct;38(7):793-801
pubmed: 9363578

Auteurs

Barry Wright (B)

University of York, York, England.

Helen Phillips (H)

Leeds and York Partnership NHS Foundation Trust, York, England.

Ann Le Couteur (A)

Newcastle University, Newcastle, United Kingdom.

Jennifer Sweetman (J)

Leeds and York Partnership NHS Foundation Trust, York, England.

Rachel Hodkinson (R)

Leeds and York Partnership NHS Foundation Trust, York, England.

Amelia Ralph-Lewis (A)

South London and Maudsley NHS Foundation Trust, London, United Kingdom.

Emily Hayward (E)

Leeds and York Partnership NHS Foundation Trust, York, England.

Alice Brennan (A)

Leeds and York Partnership NHS Foundation Trust, York, England.

Josie Mulloy (J)

Surrey and Borders Partnership NHS Foundation Trust, Leatherhead, United Kingdom.

Natalie Day (N)

Leeds and York Partnership NHS Foundation Trust, York, England.

Martin Bland (M)

University of York, York, England.

Victoria Allgar (V)

University of York, York, England.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH